Corebridge reported adjusted after-tax operating income of USD 512 million, or USD 1.12 per share, in the quarter ended June 30, 2026, per the August 4, 2026 release. GAAP results showed a net loss to common shareholders of USD 16 million, or USD 0.04 …
The stock reached its high because a cash offer replaced fundamental pricing. After a June 2026 report that Baldwin Insurance Group had hired Ardea to explore strategic options, the board approved an all-cash merger on September 14, 2026, unanimously. Completion has no financing condition …
NIQ reported second quarter revenue of USD 1,124.2 million, up 8.0% reported and 5.8% in organic constant currency, with adjusted EBITDA margin up 270 basis points to 23.3%, per the August 10, 2026 release. Net loss attributable to NIQ was USD 30.5 million, so …
Cigna Group (NYSE:CI) closed at USD 298.81 on October 15, 2026, up 3.19%, and traded at USD 302.77 intraday on October 16. No company release explains the October 15 move. It followed the October 9 Star Ratings news at Humana (NYSE:HUM). The valuation is …
Tenet Healthcare (NYSE:THC) closed at USD 275.13 on October 15, 2026, up 1.30%, per exchange data. The intraday price of USD 275.38 is 0.09% higher, own arithmetic, with an RSI of 65.8. Published market data show a trailing P/E of 10.68, reflecting GAAP EPS …
Hinge Health (NYSE:HNGE) is up from a 52-week low of USD 30.08, and its RSI of 67.4 sits below the 70 overbought threshold. Published market data show a trailing P/E of 78.04 and a forward P/E of 40.34. Quotes differ within the session: a …
Haemonetics (NYSE:HAE) has risen 2.5 times from its 52-week low of USD 48.55, own arithmetic. Published market data show a trailing P/E of 58.73 against a forward P/E of 21.95, reflecting the gap between GAAP and adjusted earnings. The catalyst was the CSL Plasma …
Gilead Sciences (NASDAQ:GILD) traded at USD 156.38 at 10:18 a.m. ET on October 16, 2026, down 0.63%, inside a 52-week range of USD 114.02 to USD 160.51 per published market data. The RSI of 64.1 is below the 70 overbought threshold, and relative volume …
Amgen (NASDAQ:AMGN) rose 0.47% to USD 436.09 on October 16, 2026 per published market data, with an RSI of 64.9 and relative volume of 0.1x early in the session. The 50-day range was USD 375.65 to USD 444.12. The dividend is USD 2.52 a …
AbbVie (NYSE:ABBV) rose 0.29% to USD 284.21 on October 16, 2026 per published market data, on relative volume of 0.2x early in the session. The shares were USD 260.69 on September 3, 2026, so they are up 9.0% since then (own arithmetic). On the …